Hengrui Pharma(SH:600276) Xin Lang Cai Jing·2025-08-21 01:23Group 1 - Core viewpoint: Heng Rui Medicine (600276.SH) reported its 2025 semi-annual results, highlighting significant institutional investor interest with 573 institutions holding a total of 4.315 billion shares, representing 65.02% of the total share capital [1] - The top ten institutional investors collectively hold 58.12% of the shares, with a slight decrease of 0.34 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, 88 funds increased their holdings, accounting for a 0.41% increase, with notable funds including Huatai-PB CSI 300 ETF and Huaxia SSE 50 ETF [2] - Conversely, 244 funds reduced their holdings, representing a 1.09% decrease, with significant reductions seen in funds like China Europe Medical Health Mixed A and E Fund CSI 300 Medical ETF [2] - A total of 185 new public funds were disclosed this period, while 150 funds were not disclosed compared to the previous quarter [2]